Is it safe to prescribe nicotinamide 500 mg twice daily to an 80‑year‑old man with mildly elevated serum creatinine and a normal urine protein‑to‑creatinine ratio?

Safety of Nicotinamide 500mg Twice Daily in an 80-Year-Old with Mild Renal Impairment

Yes, it is safe to prescribe nicotinamide 500mg twice daily to this patient, with appropriate monitoring of liver function tests during treatment. The creatinine of 113 μmol/L (approximately 1.3 mg/dL) represents mild renal impairment (eGFR likely 45-60 mL/min), and the normal protein/creatinine ratio indicates no significant proteinuria.

Key Safety Considerations

Renal Function and Nicotinamide Use

The patient's mild renal impairment does not contraindicate nicotinamide use. Multiple studies have demonstrated safety in patients with significantly worse renal function:

• Hemodialysis patients (representing severe renal failure) have been safely treated with nicotinamide 500-1500mg daily for up to 8 weeks 1, 2, 3
• Peritoneal dialysis patients tolerated doses up to 750mg twice daily 3
• Your patient's mild renal impairment (creatinine 113 μmol/L) is far less severe than end-stage renal disease

The FDA labeling states that "patients with chronic liver failure and/or renal failure should exercise extreme caution" 4, but this refers to severe renal failure, not mild elevation in creatinine.

Hepatotoxicity Risk - The Primary Concern

The main safety consideration is hepatotoxicity, not renal function. The FDA label explicitly warns that "abnormal liver function tests have been reported in persons taking daily doses of 500mg or more of niacinamide" 4. This is the critical threshold your patient is at.

Monitoring strategy:

• Obtain baseline liver function tests (ALT, AST) before starting
• Recheck at 4 weeks, then every 2-3 months during treatment
• Discontinue if transaminases rise >3x upper limit of normal
• The hepatotoxicity is reversible upon discontinuation 5

Dose-Dependent Safety Profile

The 1000mg daily dose (500mg twice daily) sits at the lower end of the therapeutic range studied:

• 500-1000mg daily: Generally well-tolerated with minimal adverse effects 1, 5
• >1500mg daily: Higher risk of adverse effects including thrombocytopenia 2, 6
• >3000mg daily: Significant hepatotoxicity risk 5

Recent systematic reviews confirm that doses under 1500mg/day typically do not require intensive clinical monitoring beyond standard liver function surveillance 6.

Common Pitfalls to Avoid

1. Don't confuse nicotinamide with niacin (nicotinic acid) - Nicotinamide has a much better tolerability profile with less flushing and fewer cardiovascular concerns 6

2. Don't withhold due to mild renal impairment alone - The evidence shows safety even in dialysis patients; mild CKD is not a contraindication

3. Don't skip baseline liver function tests - This is the essential monitoring parameter, not renal function

4. Watch for thrombocytopenia - Though uncommon at 1000mg daily, one study reported platelet count decreases 2; consider checking CBC if treatment extends beyond 8 weeks

Additional Considerations for This 80-Year-Old Patient

• Age alone is not a contraindication - Studies included elderly patients without age-specific safety concerns
• Gastrointestinal upset occurs in some patients but typically resolves during continued therapy 1
• Drug interactions: Ensure patient is not on medications that could compound hepatotoxicity risk
• Recent cardiovascular concerns at very high doses (>1500mg) relate to metabolites 7, but are not relevant at 1000mg daily

Proceed with prescription, obtain baseline LFTs, and monitor hepatic function during treatment. The mild renal impairment with normal protein/creatinine ratio does not increase risk.